**诺和诺德基金会与英伟达联手打造AI超级计算机，加速新药研发进程**
丹麦当地时间3月18日，诺和诺德基金会，这个享誉全球的医药巨头背后的企业基金会，宣布了一项重大合作计划。基金会将携手科技巨头英伟达，在丹麦本土建设一台名为Gefion的先进人工智能（AI）超级计算机。这台超级计算机将充分利用英伟达的尖端AI技术，致力于加速新药物和疗法的发现过程。
Gefion的设立旨在为丹麦的公共和私营部门的研究人员提供强大的计算资源，助力他们在医疗科研领域取得突破。通过AI的智能分析和模拟能力，科学家们有望在新药研发中缩短试验周期，提高成功率，从而更快地将创新疗法推向市场，惠及全球患者。
这一合作标志着医药行业与科技行业的深度融合，为解决全球公共卫生挑战提供了新的可能。诺和诺德基金会与英伟达的强强联合，预示着AI技术在医疗领域的应用将步入新的高度，有望开启药物研发的新篇章。
来源：科创板日报
英语如下：
**Title:** “Novo Nordisk Foundation and NVIDIA Join Forces: Denmark to Build AI Supercomputer for Accelerating Drug Discovery”
**Keywords:** AI Supercomputer, Novo Nordisk, Drug Discovery
**News Content:**
On March 18th, local Danish time, the Novo Nordisk Foundation, the corporate foundation behind the renowned global pharmaceutical giant, announced a significant collaboration. The foundation is teaming up with tech powerhouse NVIDIA to construct an advanced artificial intelligence (AI) supercomputer named Gefion within Denmark. This supercomputer will leverage NVIDIA’s cutting-edge AI technology to expedite the discovery of new drugs and therapies.
The establishment of Gefion aims to provide丹麦’s public and private sector researchers with formidable computational resources, fostering breakthroughs in medical research. By harnessing AI’s intelligent analytical and modeling capabilities, scientists anticipate reducing the time frame for drug development trials, enhancing success rates, and thereby accelerating the introduction of innovative treatments to the market, benefiting patients worldwide.
This collaboration signifies the deep integration of the pharmaceutical and technology industries, offering new possibilities for tackling global public health challenges. The union of the Novo Nordisk Foundation and NVIDIA signals a new era for AI applications in healthcare, potentially ushering in a new chapter in drug discovery.
**Source:**科创板日报 (Kechuang Board Daily)
【来源】https://www.chinastarmarket.cn/detail/1624366
Views: 1